SPU [SkyPeople Fruit Juice] DEF 14A: (Original Filing)
[]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS 3 4 2
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)
[PROXY STATEMENT OF THE COMPANY October 20, 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the Company), to be held] [EXECUTION VERSION SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT Agreement Chairman ABG Boyu Initial Sponsors G&C Temasek Hillhouse PRC Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Principal Consortium Member Principal Consortium Members Party Sponsor Parties Sponsors WHEREAS Original Consortium Agreement Transaction Company NYSE Exchange Act WHEREAS A&R Consortium Agreement] [EXECUTION VERSION CONFIDENTIAL AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT Agreement Chairman Management Roll-over Entity ABG Boyu Temasek Hillhouse Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Equity Sponsor Equity Sponsors Investor Investors Holdco Parent Merger Sub Parties Party This Amended and Restated Interim Investors Agreement (this RECITALS Original Interim Investors Agreement WHEREAS, on August 14,] []
WX [WuXi PharmaTech (Cayman)] SC 13E3/A: PROXY STATEMENT OF THE COMPANY October 20, 2015
[PROXY STATEMENT OF THE COMPANY October 20, 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the Company), to be held] [EXECUTION VERSION SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT Agreement Chairman ABG Boyu Initial Sponsors G&C Temasek Hillhouse PRC Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Principal Consortium Member Principal Consortium Members Party Sponsor Parties Sponsors WHEREAS Original Consortium Agreement Transaction Company NYSE Exchange Act WHEREAS A&R Consortium Agreement] [EXECUTION VERSION CONFIDENTIAL AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT Agreement Chairman Management Roll-over Entity ABG Boyu Temasek Hillhouse Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Equity Sponsor Equity Sponsors Investor Investors Holdco Parent Merger Sub Parties Party This Amended and Restated Interim Investors Agreement (this RECITALS Original Interim Investors Agreement WHEREAS, on August 14,] []
CBPO [China Biologic Products] SC 13G: (Original Filing)
[CUSIP No. 16938C106 1. Names of Reporting Persons 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐]
CBPO [China Biologic Products] SC 13G: CUSIP No. 16938C106 1. Names of Reporting Persons
[CUSIP No. 16938C106 1. Names of Reporting Persons 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ☐ (b) ☐]
CBPO [China Biologic Products] 8-K: (Original Filing)
[FOR RELEASE October 20, 2015 China Biologic Received Operating Permit for New Branch Collection Facility in Shandong Province BEIJING, China – October 20, 2015 – This new branch collection facility will operate under the Company’s Ningyang plasma collection station and cover the collection territory of Zaozhuang City, which has a population of 3.8 million and offers a reliable source of] []
